Oral squamous cell carcinoma (OSCC) is the most prevalent malignant neoplasm in the head and neck region, and given its significant impact on patients’ facial structures and physiological functions, ...
FIERCE-HN: A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of ficlatuzumab (HGF/cMET mAb) in combination with cetuximab in participants with recurrent or metastatic (R/M) ...
An interview with Dr. Shlomo Koyfman of the Cleveland Clinic on "Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline" which provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results